Related Experiment Video
Updated: Aug 9, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Interspecies variation in the cellular phase of blood fibrinolytic activity
1Division of Cardiology, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada.
Abstract:
In normal humans, whole blood fibrinolytic activity is three to six times greater than that of companion plasma. This additional activity derives from neutrophil enzymes, with possible contributions from other cell types. Rats and dogs are frequently used to study fibrinolysis in animal models of human disease. Compared with humans, rats are relatively neutropenic, whereas dogs have a relative neutrophilic leukocytosis. Interspecies variation in cellular phase fibrinolytic activity has not been examined. We therefore determined whole blood, plasma, and cellular phase fibrinolytic activity in 27 rats and 6 dogs, using a 125I-fibrin solid phase assay. Whole blood and plasma activities were similar in rats, consistent with very low cellular activity. Dogs, however, had high cellular phase activity, making up an average 91% of whole blood activity. These results suggest that blood fibrinolytic mechanisms in rats differ from those in humans and dogs, and that this difference should be considered when studying fibrinolysis in models of human disease.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis

